Wedge Capital Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.7M | Buy |
109,674
+1,842
| +2% | +$484K | 0.51% | 81 |
|
|
2026
Q1 | $28.8M | Sell |
107,832
-2,843
| -3% | -$770K | 0.53% | 80 |
|
|
2025
Q4 | $27.8M | Buy |
110,675
+14,892
| +16% | +$3.96M | 0.5% | 87 |
|
|
2025
Q3 | $27.5M | Sell |
95,783
-22,859
| -19% | -$6.12M | 0.47% | 81 |
|
|
2025
Q2 | $31.1M | Sell |
118,642
-19,418
| -14% | -$4.73M | 0.56% | 75 |
|
|
2025
Q1 | $32.1M | Buy |
138,060
+12,960
| +10% | +$3.14M | 0.62% | 78 |
|
|
2024
Q4 | $28.7M | Sell |
125,100
-17,868
| -12% | -$4.1M | 0.52% | 70 |
|
|
2024
Q3 | $32M | Sell |
142,968
-28,488
| -17% | -$6.26M | 0.55% | 73 |
|
|
2024
Q2 | $34.9M | Sell |
171,456
-3,464
| -2% | -$705K | 0.62% | 66 |
|
|
2024
Q1 | $38.2M | Buy |
174,920
+32,679
| +23% | +$7.2M | 0.62% | 71 |
|
|
2023
Q4 | $32.3M | Sell |
142,241
-6,627
| -4% | -$1.39M | 0.58% | 56 |
|
|
2023
Q3 | $29.9M | Sell |
148,868
-15,112
| -9% | -$3.19M | 0.59% | 68 |
|
|
2023
Q2 | $34M | Sell |
163,980
-29,388
| -15% | -$5.7M | 0.54% | 38 |
|
|
2023
Q1 | $38.1M | Buy |
193,368
+3,138
| +2% | +$646K | 0.64% | 32 |
|
|
2022
Q4 | $38.5M | Buy |
190,230
+4,418
| +2% | +$863K | 0.62% | 42 |
|
|
2022
Q3 | $32.7M | Buy |
185,812
+13,513
| +8% | +$2.77M | 0.55% | 74 |
|
|
2022
Q2 | $34.7M | Buy |
172,299
+35,033
| +26% | +$7.47M | 0.55% | 66 |
|
|
2022
Q1 | $31.1M | Buy |
137,266
+9,633
| +8% | +$2.27M | 0.42% | 115 |
|
|
2021
Q4 | $34.5M | Buy |
127,633
+4,584
| +4% | +$1.13M | 0.43% | 95 |
|
|
2021
Q3 | $29.8M | Sell |
123,049
-12,850
| -9% | -$3.24M | 0.38% | 99 |
|
|
2021
Q2 | $32.2M | Sell |
135,899
-15,336
| -10% | -$3.49M | 0.39% | 81 |
|
|
2021
Q1 | $33.1M | Sell |
151,235
-3,404
| -2% | -$683K | 0.39% | 93 |
|
|
2020
Q4 | $27M | Sell |
154,639
-17,809
| -10% | -$3.08M | 0.31% | 123 |
|
|
2020
Q3 | $27.9M | Buy |
+172,448
| New | +$27.3M | 0.37% | 78 |
|
|
2020
Q2 | – | Sell |
-285,747
| Closed | -$31M | – | 538 |
|
|
2020
Q1 | $31M | Buy |
285,747
+1,631
| +0.6% | +$235K | 0.54% | 75 |
|
|
2019
Q4 | $41.3M | Buy |
284,116
+55,253
| +24% | +$7.98M | 0.46% | 82 |
|
|
2019
Q3 | $33M | Sell |
228,863
-922
| -0.4% | -$135K | 0.38% | 101 |
|
|
2019
Q2 | $34.1M | Buy |
+229,785
| New | +$32.1M | 0.39% | 91 |
|
|
2015
Q4 | – | Sell |
-379,243
| Closed | -$35.3M | – | 604 |
|
|
2015
Q3 | $35.3M | Sell |
379,243
-38,499
| -9% | -$3.98M | 0.37% | 87 |
|
|
2015
Q2 | $43.5M | Sell |
417,742
-81,888
| -16% | -$8.52M | 0.42% | 78 |
|
|
2015
Q1 | $54.1M | Buy |
499,630
+491,482
| +6,032% | +$50.5M | 0.54% | 46 |
|
|
2014
Q4 | $755K | Sell |
8,148
-146
| -2% | -$12.9K | 0.01% | 367 |
|
|
2014
Q3 | $725K | Buy |
8,294
+582
| +8% | +$52.6K | 0.01% | 372 |
|
|
2014
Q2 | $678K | Buy |
7,712
+3,376
| +78% | +$292K | 0.01% | 370 |
|
|
2014
Q1 | $366K | Sell |
4,336
-204
| -4% | -$16.3K | ﹤0.01% | 400 |
|
|
2013
Q4 | $356K | Buy |
+4,540
| New | +$387K | ﹤0.01% | 399 |
|
Other funds holding LH
RRAM
SFA
HPCM
MCM
WIC
GIA
NAM
CIM
Wedge Capital Management's LH Position: Q2 2026 in Review
Wedge Capital Management increased its Labcorp (LH) stake by 1.7% in Q2 2026, buying an estimated $484K and bringing the position to 109,674 shares worth $30.7M. The position accounts for 0.51% of the portfolio, ranked #81.
Wedge Capital Management first reported a position in LH in Q4 2013 and has held it in 36 quarters since. The position peaked at $54.1M in Q1 2015. 147 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Wedge Capital Management held 109,674 shares of Labcorp worth $30.7M as of Q2 2026.
- Wedge Capital Management bought 1,842 Labcorp shares in Q2 2026, an estimated $484K.
- Labcorp made up 0.51% of Wedge Capital Management's portfolio in Q2 2026, its #81 holding.
- Wedge Capital Management first reported a position in Labcorp in Q4 2013 and has held it in 36 quarters since.
- Wedge Capital Management's Labcorp position peaked at $54.1M in Q1 2015.
- 147 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.